Canada · Biotechnology startup

Reunion Neuroscience

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

Funding reportedLast round: Series A

BiotechnologyToronto, Canada

What company datasets say Reunion Neuroscience raised

Funding, as reported

Reported in all103Min the source's currency
Rounds1
Last roundSeries A
Last round dateMay 2024
Investors listed7

Founders and team

From Reunion Neuroscience's own website: 22 on the team.

  • Dr. Sahil KirpekarPresident & Chief Executive Officer
  • Dr. Nathan BrysonChief Scientific Officer
  • Edward SmithChief Financial Officer
  • Mark TheeuwesChief Operating Officer
  • Brian ShusterBoard Member
  • Dr. Alan SchatzbergBoard Member
  • Dr. Anita H. ClaytonBoard Member
  • Dr. Ansbert GadickeBoard Member
  • Dr. Charles NemeroffBoard Member
  • Dr. Jerry RosenbaumBoard Member
  • Dr. Kristina DeligiannidisBoard Member
  • Dr. Manish AgarwalBoard Member
  • Dr. Matthew W. JohnsonBoard Member
  • Dr. Michael Van AmeringenBoard Member
  • Dr. Natalie SacksBoard Member
  • Dr. Peter HendricksBoard Member
  • Dr. Pini OrbachBoard Member
  • Dr. Rachel YehudaBoard Member

And 4 more on the team.

On 3 portfolio pages

Investors who name them

Each firm lists Reunion Neuroscience on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in Canada

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Reunion Neuroscience in front of investors. Or tell us what we have wrong.

List your startupSend a correction